Clinical Practice Guidelines (CPG) on EBMonFHIR
1.0.2 - qa-preview

This page is part of the CPG-on-EBMonFHIR Implementation Guide (1.0.2).

Example Evidence: Mortality Outcome for Dexamethasone application

Active as of 2024-10-21

Generated Narrative: Evidence DexamethasoneOutcomeMortality

url: Evidence ExampleOutcomeEvidence

name: ExampleOutcomeEvidence

status: Active

experimental:

date: 2024-10-21 14:50:59+0000

copyright:

RelatedArtifacts

-TypeResourceReference
*CitationCitation SystemicCorticosteroidsForTheTreatmentOfCOVID19

variableDefinition

variableRole: population

observed: Group StudyCohortCriteriaSystemicCorticosteroidsCOVID19

intended: EvidenceVariable StudyEligibilityCriteriaSystemicCorticosteroidsCOVID19

variableDefinition

variableRole: measured variable

observed: EvidenceVariable AllCauseMortality

synthesisType: not applicable

statistic

description:

Relative effect of intervention vs. comparator

statisticType: Relative Risk

quantity: 0.89

SampleSizes

-NumberOfStudiesNumberOfParticipants
*97930

AttributeEstimates

-TypeLevelRange
*Confidence interval0.950.8-1

statistic

description:

Baseline risk/result in the comparison group

statisticType: Incidence

quantity: 245 1/1000 (Details: UCUM code1/1000 = '1/1000')